CIPLA vs SUNPHARMA: Which Is Better on the Numbers?

Cipla Ltd (CIPLA) trades at ₹1415 on a P/E of 31.4, while Sun Pharmaceutical Industries Ltd (SUNPHARMA) trades at ₹1954 on a P/E of 37.7. On valuation, Cipla Ltd is cheaper on earnings (P/E 31.4 vs 37.7). This is a data comparison, not a recommendation.

Cipla Ltd

CIPLA
₹1,415.1

Sun Pharmaceutical Industries Ltd

SUNPHARMA
₹1,954

CIPLA vs SUNPHARMA - full comparison

MetricCIPLASUNPHARMA
Share price₹1,415.1₹1,954
P/E ratio (lower = cheaper)31.4037.70
ROE (higher = better)11.60%16.00%
ROCE (higher = better)15.50%20.50%
Dividend yield0.93%0.82%
Annualised return (history)-2.9%+10.0%
Volatility (lower = steadier)22%20%
1-year forecast (Monte Carlo median)₹1,340.65₹2,121.13
Cheapest MTF margin22% (Dhan)22% (Dhan)

Forecast as of 24 Jul

How CIPLA and SUNPHARMA compare

Not investment advice. This page compares publicly available metrics and a statistical forecast for information only. The 1-year forecast is a Monte Carlo projection from historical volatility, not a prediction. Do your own research or consult a SEBI-registered adviser before investing.

More stock comparisons

Related tools